首页 > 最新文献

Cell stem cell最新文献

英文 中文
All roads lead to cholesterol: Modulating lipid biosynthesis in multiple sclerosis patient-derived models 条条大路通罗马调节多发性硬化症患者衍生模型中的脂质生物合成
IF 23.9 1区 医学 Q1 CELL & TISSUE ENGINEERING Pub Date : 2024-11-07 DOI: 10.1016/j.stem.2024.10.011
Sophie Eichhorner, Larissa Traxler, Oliver Borgogno, Jerome Mertens
Studies from Ionescu et al.1 and Clayton et al.2 using multiple sclerosis (MS) patient-derived cell models underscore cholesterol metabolism’s role in inflammatory and dysfunctional cell phenotypes in the disease. Inhibiting cholesterol biosynthesis ameliorated critical cellular phenotypes, emphasizing the need to further investigate this pathway as a potential target for MS treatment.
Ionescu 等人1 和 Clayton 等人2 利用多发性硬化症(MS)患者衍生细胞模型进行的研究强调了胆固醇代谢在该疾病的炎症和功能障碍细胞表型中的作用。抑制胆固醇的生物合成可以改善关键的细胞表型,这强调了进一步研究这一途径作为治疗多发性硬化症潜在靶点的必要性。
{"title":"All roads lead to cholesterol: Modulating lipid biosynthesis in multiple sclerosis patient-derived models","authors":"Sophie Eichhorner, Larissa Traxler, Oliver Borgogno, Jerome Mertens","doi":"10.1016/j.stem.2024.10.011","DOIUrl":"https://doi.org/10.1016/j.stem.2024.10.011","url":null,"abstract":"Studies from Ionescu et al.<span><span><sup>1</sup></span></span> and Clayton et al.<span><span><sup>2</sup></span></span> using multiple sclerosis (MS) patient-derived cell models underscore cholesterol metabolism’s role in inflammatory and dysfunctional cell phenotypes in the disease. Inhibiting cholesterol biosynthesis ameliorated critical cellular phenotypes, emphasizing the need to further investigate this pathway as a potential target for MS treatment.","PeriodicalId":9665,"journal":{"name":"Cell stem cell","volume":"33 1","pages":""},"PeriodicalIF":23.9,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142594597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nurturing protectors: Macrophages in the human pancreatic islet 培育保护者人类胰岛中的巨噬细胞
IF 23.9 1区 医学 Q1 CELL & TISSUE ENGINEERING Pub Date : 2024-11-07 DOI: 10.1016/j.stem.2024.10.006
Christopher Z.W. Lee, Francesca M. Spagnoli
Two recent publications in Cell Stem Cell, Yang et al.1 and Migliorini et al.,2 utilized pluripotent stem cell-derived co-culture systems to explore the role of macrophages within the pancreatic islet during development and disease states.
最近,Yang等人1和Migliorini等人2在《细胞干细胞》(Cell Stem Cell)杂志上发表了两篇文章,利用多能干细胞衍生的共培养系统,探索巨噬细胞在胰岛发育和疾病状态中的作用。
{"title":"Nurturing protectors: Macrophages in the human pancreatic islet","authors":"Christopher Z.W. Lee, Francesca M. Spagnoli","doi":"10.1016/j.stem.2024.10.006","DOIUrl":"https://doi.org/10.1016/j.stem.2024.10.006","url":null,"abstract":"Two recent publications in <em>Cell Stem Cell</em>, Yang et al.<span><span><sup>1</sup></span></span> and Migliorini et al.,<span><span><sup>2</sup></span></span> utilized pluripotent stem cell-derived co-culture systems to explore the role of macrophages within the pancreatic islet during development and disease states.","PeriodicalId":9665,"journal":{"name":"Cell stem cell","volume":"68 1","pages":""},"PeriodicalIF":23.9,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142594600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity 在人类 iPSC-心肌细胞中进行 CRISPRi/a 筛选,确定糖酵解激活是多柔比星诱导的心脏毒性的药物靶点
IF 23.9 1区 医学 Q1 CELL & TISSUE ENGINEERING Pub Date : 2024-11-07 DOI: 10.1016/j.stem.2024.10.007
Chun Liu, Mengcheng Shen, Yanxia Liu, Amit Manhas, Shane Rui Zhao, Mao Zhang, Nadjet Belbachir, Lu Ren, Joe Z. Zhang, Arianne Caudal, Masataka Nishiga, Dilip Thomas, Angela Zhang, Huaxiao Yang, Yang Zhou, Mohamed Ameen, Nazish Sayed, June-Wha Rhee, Lei S. Qi, Joseph C. Wu
Doxorubicin is limited in its therapeutic utility due to its life-threatening cardiovascular side effects. Here, we present an integrated drug discovery pipeline combining human induced pluripotent stem cell (iPSC)-derived cardiomyocytes (iCMs), CRISPR interference and activation (CRISPRi/a) bidirectional pooled screens, and a small-molecule screening to identify therapeutic targets mitigating doxorubicin-induced cardiotoxicity (DIC) without compromising its oncological effects. The screens revealed several previously unreported candidate genes contributing to DIC, including carbonic anhydrase 12 (CA12). Genetic inhibition of CA12 protected iCMs against DIC by improving cell survival, sarcomere structural integrity, contractile function, and calcium handling. Indisulam, a CA12 antagonist, can effectively attenuate DIC in iCMs, engineered heart tissue, and animal models. Mechanistically, doxorubicin-induced CA12 potentiated a glycolytic activation in cardiomyocytes, contributing to DIC by interfering with cellular metabolism and functions. Collectively, our study provides a roadmap for future drug discovery efforts, potentially leading to more targeted therapies with minimal off-target toxicity.
多柔比星因其危及生命的心血管副作用而限制了其治疗用途。在这里,我们介绍了一个综合药物发现流水线,该流水线结合了人类诱导多能干细胞(iPSC)衍生的心肌细胞(iCMs)、CRISPR干扰和激活(CRISPRi/a)双向集合筛选以及小分子筛选,以确定可减轻多柔比星诱导的心脏毒性(DIC)而不影响其肿瘤学效应的治疗靶点。筛选发现了几个以前未报道过的导致 DIC 的候选基因,包括碳酸酐酶 12(CA12)。基因抑制 CA12 可改善细胞存活率、肌节结构完整性、收缩功能和钙处理,从而保护 iCM 免受 DIC 的影响。CA12 拮抗剂茚地舒兰能有效减轻 iCMs、工程心脏组织和动物模型中的 DIC。从机理上讲,多柔比星诱导的 CA12 可增强心肌细胞中的糖酵解激活,通过干扰细胞代谢和功能导致 DIC。总之,我们的研究为未来的药物发现工作提供了路线图,有可能开发出更有针对性且脱靶毒性最小的疗法。
{"title":"CRISPRi/a screens in human iPSC-cardiomyocytes identify glycolytic activation as a druggable target for doxorubicin-induced cardiotoxicity","authors":"Chun Liu, Mengcheng Shen, Yanxia Liu, Amit Manhas, Shane Rui Zhao, Mao Zhang, Nadjet Belbachir, Lu Ren, Joe Z. Zhang, Arianne Caudal, Masataka Nishiga, Dilip Thomas, Angela Zhang, Huaxiao Yang, Yang Zhou, Mohamed Ameen, Nazish Sayed, June-Wha Rhee, Lei S. Qi, Joseph C. Wu","doi":"10.1016/j.stem.2024.10.007","DOIUrl":"https://doi.org/10.1016/j.stem.2024.10.007","url":null,"abstract":"Doxorubicin is limited in its therapeutic utility due to its life-threatening cardiovascular side effects. Here, we present an integrated drug discovery pipeline combining human induced pluripotent stem cell (iPSC)-derived cardiomyocytes (iCMs), CRISPR interference and activation (CRISPRi/a) bidirectional pooled screens, and a small-molecule screening to identify therapeutic targets mitigating doxorubicin-induced cardiotoxicity (DIC) without compromising its oncological effects. The screens revealed several previously unreported candidate genes contributing to DIC, including carbonic anhydrase 12 (CA12). Genetic inhibition of CA12 protected iCMs against DIC by improving cell survival, sarcomere structural integrity, contractile function, and calcium handling. Indisulam, a CA12 antagonist, can effectively attenuate DIC in iCMs, engineered heart tissue, and animal models. Mechanistically, doxorubicin-induced CA12 potentiated a glycolytic activation in cardiomyocytes, contributing to DIC by interfering with cellular metabolism and functions. Collectively, our study provides a roadmap for future drug discovery efforts, potentially leading to more targeted therapies with minimal off-target toxicity.","PeriodicalId":9665,"journal":{"name":"Cell stem cell","volume":"149 1","pages":""},"PeriodicalIF":23.9,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142594596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
To BE or to PE: Prime editors provide more choices for epitope-editing-based immunotherapy 要BE还是要PE:主编辑器为基于表位编辑的免疫疗法提供了更多选择
IF 23.9 1区 医学 Q1 CELL & TISSUE ENGINEERING Pub Date : 2024-11-07 DOI: 10.1016/j.stem.2024.10.009
S.M. Yin, D.L. Li
Epitope editing is a promising strategy for protecting hematopoietic cells from eradication by immunotherapies. Recently, in Cell Stem Cell, Ji et al. applied both base editing (BE) and prime editing (PE) to alter the epitope of CD123 in hematopoietic stem cells for CAR-T therapy against acute myeloid leukemia.1
表位编辑是一种保护造血细胞免受免疫疗法根除的有效策略。最近,在《细胞干细胞》(Cell Stem Cell)杂志上,Ji 等人应用碱基编辑(BE)和质粒编辑(PE)改变造血干细胞中 CD123 的表位,用于治疗急性髓性白血病的 CAR-T 疗法。
{"title":"To BE or to PE: Prime editors provide more choices for epitope-editing-based immunotherapy","authors":"S.M. Yin, D.L. Li","doi":"10.1016/j.stem.2024.10.009","DOIUrl":"https://doi.org/10.1016/j.stem.2024.10.009","url":null,"abstract":"Epitope editing is a promising strategy for protecting hematopoietic cells from eradication by immunotherapies. Recently, in <em>Cell Stem Cell</em>, Ji et al. applied both base editing (BE) and prime editing (PE) to alter the epitope of CD123 in hematopoietic stem cells for CAR-T therapy against acute myeloid leukemia.<span><span><sup>1</sup></span></span>","PeriodicalId":9665,"journal":{"name":"Cell stem cell","volume":"33 1","pages":""},"PeriodicalIF":23.9,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142594599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trained immunity in the bone marrow: Hub of autoimmunity 骨髓中训练有素的免疫力自身免疫的枢纽
IF 23.9 1区 医学 Q1 CELL & TISSUE ENGINEERING Pub Date : 2024-11-07 DOI: 10.1016/j.stem.2024.10.008
Mihai G. Netea, Leo A.B. Joosten
An inappropriate induction of trained immunity in the bone marrow progenitors of immune cells has been described to underlie chronic inflammatory processes. Mills and colleagues’ recently published paper in Cell Stem Cell shows that maladaptive trained immunity drives inflammation in autoimmune processes,1 opening a new area of research in autoimmunity.
据描述,在骨髓免疫细胞祖细胞中不适当地诱导训练有素的免疫力是慢性炎症过程的基础。米尔斯及其同事最近在《细胞干细胞》(Cell Stem Cell)杂志上发表的论文表明,适应不良的训练有素的免疫力会驱动自身免疫过程中的炎症1,从而开辟了自身免疫研究的新领域。
{"title":"Trained immunity in the bone marrow: Hub of autoimmunity","authors":"Mihai G. Netea, Leo A.B. Joosten","doi":"10.1016/j.stem.2024.10.008","DOIUrl":"https://doi.org/10.1016/j.stem.2024.10.008","url":null,"abstract":"An inappropriate induction of trained immunity in the bone marrow progenitors of immune cells has been described to underlie chronic inflammatory processes. Mills and colleagues’ recently published paper in <em>Cell Stem Cell</em> shows that maladaptive trained immunity drives inflammation in autoimmune processes,<span><span><sup>1</sup></span></span> opening a new area of research in autoimmunity.","PeriodicalId":9665,"journal":{"name":"Cell stem cell","volume":"9 1","pages":""},"PeriodicalIF":23.9,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142594598","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reconsidering the 14-day rule in human embryo research: Advice from the Dutch Health Council 重新考虑人类胚胎研究中的 14 天规则:荷兰卫生委员会的建议
IF 23.9 1区 医学 Q1 CELL & TISSUE ENGINEERING Pub Date : 2024-11-07 DOI: 10.1016/j.stem.2024.09.019
Hafez Ismaili M’hamdi, Guido de Wert
The Dutch Health Council has advised to extend the 14-day rule to 28 days and to subsume integrated stem cell-based embryo models under the same legislative regime as natural embryos. Public discussion is necessary due to the ethical issues that may emerge from studying integrated and non-integrated embryo models.
荷兰卫生委员会建议将 14 天规则延长至 28 天,并将基于干细胞的整合胚胎模型纳入与天然胚胎相同的法律制度下。由于研究整合和非整合胚胎模型可能会出现伦理问题,因此有必要进行公开讨论。
{"title":"Reconsidering the 14-day rule in human embryo research: Advice from the Dutch Health Council","authors":"Hafez Ismaili M’hamdi, Guido de Wert","doi":"10.1016/j.stem.2024.09.019","DOIUrl":"https://doi.org/10.1016/j.stem.2024.09.019","url":null,"abstract":"The Dutch Health Council has advised to extend the 14-day rule to 28 days and to subsume integrated stem cell-based embryo models under the same legislative regime as natural embryos. Public discussion is necessary due to the ethical issues that may emerge from studying integrated and non-integrated embryo models.","PeriodicalId":9665,"journal":{"name":"Cell stem cell","volume":"47 1","pages":""},"PeriodicalIF":23.9,"publicationDate":"2024-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142594601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Maturation and persistence of CAR T cells derived from human pluripotent stem cells via chemical inhibition of G9a/GLP 通过化学抑制 G9a/GLP 实现人类多能干细胞 CAR T 细胞的成熟和持久性
IF 23.9 1区 医学 Q1 CELL & TISSUE ENGINEERING Pub Date : 2024-11-05 DOI: 10.1016/j.stem.2024.10.004
Ran Jing, Marcelo Falchetti, Tianxiao Han, Mohamad Najia, Luca T. Hensch, Eleanor Meader, Edroaldo Lummertz da Rocha, Martin Kononov, Stephanie Wang, Trevor Bingham, Zhiheng Li, Yunliang Zhao, Katie Frenis, Caroline Kubaczka, Song Yang, Deepak Jha, Gabriela F. Rodrigues-Luiz, R. Grant Rowe, Thorsten M. Schlaeger, Marcela V. Maus, George Q. Daley
Elucidating mechanisms of T cell development can guide in vitro T cell differentiation from induced pluripotent stem cells (iPSCs) and facilitate off-the-shelf T cell-based immunotherapies. Using a stroma-free human iPSC-T cell differentiation platform, we screened for epigenetic modulators that influence T cell specification and identified the H3K9-directed histone methyltransferases G9a/GLP as repressors of T cell fate. We show that G9a/GLP inhibition during specific time windows of differentiation of hematopoietic stem and progenitor cells (HSPCs) skews cell fates toward lymphoid lineages. Inhibition of G9a/GLP promotes the production of lymphoid cells during zebrafish embryonic hematopoiesis, demonstrating the evolutionary conservation of G9a/GLP function. Importantly, chemical inhibition of G9a/GLP facilitates the generation of mature iPSC-T cells that bear transcriptional similarity to peripheral blood αβ T cells. When engineered to express chimeric antigen receptors, the epigenetically engineered iPSC-T cells exhibit enhanced effector functions in vitro and durable, persistent antitumor activity in a xenograft tumor-rechallenge model.
阐明T细胞的发育机制可以指导诱导多能干细胞(iPSC)的体外T细胞分化,并促进基于T细胞的现成免疫疗法。利用无基质的人类 iPSC-T 细胞分化平台,我们筛选了影响 T 细胞分化的表观遗传调节剂,并确定了 H3K9 引导的组蛋白甲基转移酶 G9a/GLP 是 T 细胞命运的抑制因子。我们发现,在造血干细胞和祖细胞(HSPCs)分化的特定时间窗口抑制 G9a/GLP 会使细胞命运向淋巴系倾斜。在斑马鱼胚胎造血过程中,抑制 G9a/GLP 可促进淋巴细胞的产生,这证明了 G9a/GLP 功能的进化保护。重要的是,化学抑制 G9a/GLP 可促进成熟 iPSC-T 细胞的生成,这些细胞与外周血 αβ T 细胞具有转录相似性。当被设计表达嵌合抗原受体时,经表观遗传学设计的 iPSC-T 细胞在体外表现出更强的效应功能,并在异种移植肿瘤挑战模型中表现出持久的抗肿瘤活性。
{"title":"Maturation and persistence of CAR T cells derived from human pluripotent stem cells via chemical inhibition of G9a/GLP","authors":"Ran Jing, Marcelo Falchetti, Tianxiao Han, Mohamad Najia, Luca T. Hensch, Eleanor Meader, Edroaldo Lummertz da Rocha, Martin Kononov, Stephanie Wang, Trevor Bingham, Zhiheng Li, Yunliang Zhao, Katie Frenis, Caroline Kubaczka, Song Yang, Deepak Jha, Gabriela F. Rodrigues-Luiz, R. Grant Rowe, Thorsten M. Schlaeger, Marcela V. Maus, George Q. Daley","doi":"10.1016/j.stem.2024.10.004","DOIUrl":"https://doi.org/10.1016/j.stem.2024.10.004","url":null,"abstract":"Elucidating mechanisms of T cell development can guide <em>in vitro</em> T cell differentiation from induced pluripotent stem cells (iPSCs) and facilitate off-the-shelf T cell-based immunotherapies. Using a stroma-free human iPSC-T cell differentiation platform, we screened for epigenetic modulators that influence T cell specification and identified the H3K9-directed histone methyltransferases G9a/GLP as repressors of T cell fate. We show that G9a/GLP inhibition during specific time windows of differentiation of hematopoietic stem and progenitor cells (HSPCs) skews cell fates toward lymphoid lineages. Inhibition of G9a/GLP promotes the production of lymphoid cells during zebrafish embryonic hematopoiesis, demonstrating the evolutionary conservation of G9a/GLP function. Importantly, chemical inhibition of G9a/GLP facilitates the generation of mature iPSC-T cells that bear transcriptional similarity to peripheral blood αβ T cells. When engineered to express chimeric antigen receptors, the epigenetically engineered iPSC-T cells exhibit enhanced effector functions <em>in vitro</em> and durable, persistent antitumor activity in a xenograft tumor-rechallenge model.","PeriodicalId":9665,"journal":{"name":"Cell stem cell","volume":"84 1","pages":""},"PeriodicalIF":23.9,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142580571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer’s disease model 在嵌合型阿尔茨海默病模型中,消耗小胶质细胞可减少人类神经元与 APOE4 相关的病变
IF 23.9 1区 医学 Q1 CELL & TISSUE ENGINEERING Pub Date : 2024-11-04 DOI: 10.1016/j.stem.2024.10.005
Antara Rao, Nuo Chen, Min Joo Kim, Jessica Blumenfeld, Oscar Yip, Zherui Liang, David Shostak, Yanxia Hao, Maxine R. Nelson, Nicole Koutsodendris, Brian Grone, Leo Ding, Seo Yeon Yoon, Patrick Arriola, Misha Zilberter, Yadong Huang
Despite strong evidence supporting the important roles of both apolipoprotein E4 (APOE4) and microglia in Alzheimer’s disease (AD) pathogenesis, the effects of microglia on neuronal APOE4-related AD pathogenesis remain elusive. To examine such effects, we utilized microglial depletion in a chimeric model with induced pluripotent stem cell (iPSC)-derived human neurons in mouse hippocampus. Specifically, we transplanted homozygous APOE4, isogenic APOE3, and APOE-knockout (APOE-KO) iPSC-derived human neurons into the hippocampus of human APOE3 or APOE4 knockin mice and then depleted microglia in half of the chimeric mice. We found that both neuronal APOE and microglial presence were important for the formation of Aβ and tau pathologies in an APOE isoform-dependent manner (APOE4 > APOE3). Single-cell RNA sequencing analysis identified two pro-inflammatory microglial subtypes with elevated MHC-II gene expression enriched in chimeric mice with human APOE4 neuron transplants. These findings highlight the concerted roles of neuronal APOE, especially APOE4, and microglia in AD pathogenesis.
尽管有强有力的证据支持脂蛋白E4(APOE4)和小胶质细胞在阿尔茨海默病(AD)发病机制中的重要作用,但小胶质细胞对神经元APOE4相关AD发病机制的影响仍然难以捉摸。为了研究这种影响,我们在小鼠海马与诱导多能干细胞(iPSC)衍生的人类神经元的嵌合模型中利用了小胶质细胞耗竭。具体来说,我们将同基因 APOE4、同基因 APOE3 和 APOE 基因敲除(APOE-KO)iPSC 衍生的人类神经元移植到人类 APOE3 或 APOE4 基因敲除小鼠的海马中,然后在一半的嵌合小鼠中消耗小胶质细胞。我们发现,神经元 APOE 和小胶质细胞的存在对 Aβ 和 tau 病理学的形成都很重要,而这种形成是以 APOE 同工酶依赖性(APOE4 > APOE3)的方式进行的。单细胞 RNA 测序分析发现,在人类 APOE4 神经元移植的嵌合小鼠中,有两种促炎性小胶质细胞亚型的 MHC-II 基因表达增高。这些发现凸显了神经元 APOE(尤其是 APOE4)和小胶质细胞在注意力缺失症发病机制中的协同作用。
{"title":"Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer’s disease model","authors":"Antara Rao, Nuo Chen, Min Joo Kim, Jessica Blumenfeld, Oscar Yip, Zherui Liang, David Shostak, Yanxia Hao, Maxine R. Nelson, Nicole Koutsodendris, Brian Grone, Leo Ding, Seo Yeon Yoon, Patrick Arriola, Misha Zilberter, Yadong Huang","doi":"10.1016/j.stem.2024.10.005","DOIUrl":"https://doi.org/10.1016/j.stem.2024.10.005","url":null,"abstract":"Despite strong evidence supporting the important roles of both apolipoprotein E4 (APOE4) and microglia in Alzheimer’s disease (AD) pathogenesis, the effects of microglia on neuronal APOE4-related AD pathogenesis remain elusive. To examine such effects, we utilized microglial depletion in a chimeric model with induced pluripotent stem cell (iPSC)-derived human neurons in mouse hippocampus. Specifically, we transplanted homozygous APOE4, isogenic APOE3, and APOE-knockout (APOE-KO) iPSC-derived human neurons into the hippocampus of human APOE3 or APOE4 knockin mice and then depleted microglia in half of the chimeric mice. We found that both neuronal APOE and microglial presence were important for the formation of Aβ and tau pathologies in an APOE isoform-dependent manner (APOE4 &gt; APOE3). Single-cell RNA sequencing analysis identified two pro-inflammatory microglial subtypes with elevated MHC-II gene expression enriched in chimeric mice with human APOE4 neuron transplants. These findings highlight the concerted roles of neuronal APOE, especially APOE4, and microglia in AD pathogenesis.","PeriodicalId":9665,"journal":{"name":"Cell stem cell","volume":"68 1","pages":""},"PeriodicalIF":23.9,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142574506","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
m6A/YTHDF2-mediated mRNA decay targets TGF-β signaling to suppress the quiescence acquisition of early postnatal mouse hippocampal NSCs m6A/YTHDF2介导的mRNA衰变靶向TGF-β信号传导,抑制出生后早期小鼠海马NSC的静止获得
IF 23.9 1区 医学 Q1 CELL & TISSUE ENGINEERING Pub Date : 2024-10-29 DOI: 10.1016/j.stem.2024.10.002
Feng Zhang, Yao Fu, Dennisse Jimenez-Cyrus, Ting Zhao, Yachen Shen, Yusha Sun, Zhijian Zhang, Qing Wang, Riki Kawaguchi, Daniel H. Geschwind, Chuan He, Guo-li Ming, Hongjun Song
Quiescence acquisition of proliferating neural stem cells (NSCs) is required to establish the adult NSC pool. The underlying molecular mechanisms are not well understood. Here, we showed that conditional deletion of the m6A reader Ythdf2, which promotes mRNA decay, in proliferating NSCs in the early postnatal mouse hippocampus elevated quiescence acquisition in a cell-autonomous fashion with decreased neurogenesis. Multimodal profiling of m6A modification, YTHDF2 binding, and mRNA decay in hippocampal NSCs identified shared targets in multiple transforming growth factor β (TGF-β)-signaling-pathway components, including TGF-β ligands, maturation factors, receptors, transcription regulators, and signaling regulators. Functionally, Ythdf2 deletion led to TGF-β-signaling activation in NSCs, suppression of which rescued elevated quiescence acquisition of proliferating hippocampal NSCs. Our study reveals the dynamic nature and critical roles of mRNA decay in establishing the quiescent adult hippocampal NSC pool and uncovers a distinct mode of epitranscriptomic control via co-regulation of multiple components of the same signaling pathway.
增殖的神经干细胞(NSC)需要获得休眠状态才能建立成体 NSC 库。其潜在的分子机制尚不十分清楚。在这里,我们发现,有条件地缺失促进mRNA衰变的m6A阅读器Ythdf2,会以细胞自主的方式提高出生后早期小鼠海马中增殖的神经干细胞的静止获得,同时减少神经发生。对海马NSCs中的m6A修饰、YTHDF2结合和mRNA衰变进行的多模式分析发现了多种转化生长因子β(TGF-β)-信号通路成分的共同靶点,包括TGF-β配体、成熟因子、受体、转录调节因子和信号调节因子。从功能上讲,Ythdf2的缺失会导致NSCs中TGF-β信号的激活,而抑制TGF-β信号的激活则会挽救增殖的海马NSCs获得的静止状态的升高。我们的研究揭示了mRNA衰变在建立静止的成体海马NSC池中的动态性质和关键作用,并发现了一种通过共同调控同一信号通路的多个成分来控制外显子转录组的独特模式。
{"title":"m6A/YTHDF2-mediated mRNA decay targets TGF-β signaling to suppress the quiescence acquisition of early postnatal mouse hippocampal NSCs","authors":"Feng Zhang, Yao Fu, Dennisse Jimenez-Cyrus, Ting Zhao, Yachen Shen, Yusha Sun, Zhijian Zhang, Qing Wang, Riki Kawaguchi, Daniel H. Geschwind, Chuan He, Guo-li Ming, Hongjun Song","doi":"10.1016/j.stem.2024.10.002","DOIUrl":"https://doi.org/10.1016/j.stem.2024.10.002","url":null,"abstract":"Quiescence acquisition of proliferating neural stem cells (NSCs) is required to establish the adult NSC pool. The underlying molecular mechanisms are not well understood. Here, we showed that conditional deletion of the m<sup>6</sup>A reader <em>Ythdf2</em>, which promotes mRNA decay, in proliferating NSCs in the early postnatal mouse hippocampus elevated quiescence acquisition in a cell-autonomous fashion with decreased neurogenesis. Multimodal profiling of m<sup>6</sup>A modification, YTHDF2 binding, and mRNA decay in hippocampal NSCs identified shared targets in multiple transforming growth factor β (TGF-β)-signaling-pathway components, including TGF-β ligands, maturation factors, receptors, transcription regulators, and signaling regulators. Functionally, <em>Ythdf2</em> deletion led to TGF-β-signaling activation in NSCs, suppression of which rescued elevated quiescence acquisition of proliferating hippocampal NSCs. Our study reveals the dynamic nature and critical roles of mRNA decay in establishing the quiescent adult hippocampal NSC pool and uncovers a distinct mode of epitranscriptomic control via co-regulation of multiple components of the same signaling pathway.","PeriodicalId":9665,"journal":{"name":"Cell stem cell","volume":"14 1","pages":""},"PeriodicalIF":23.9,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142536558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assembloid models of cell-cell interaction to study tissue and disease biology 研究组织和疾病生物学的细胞-细胞相互作用组装体模型
IF 23.9 1区 医学 Q1 CELL & TISSUE ENGINEERING Pub Date : 2024-10-24 DOI: 10.1016/j.stem.2024.09.017
Massimo M. Onesto, Ji-il Kim, Sergiu P. Pasca
Neurodevelopment involves the migration, projection, and integration of various cell types across different regions of the nervous system. Assembloids are self-organizing systems formed by the integration of multiple organoids or cell types. Here, we outline the generation and application of assembloids. We illustrate how assembloids recapitulate critical neurodevelopmental steps, like migration, axon projection, and circuit formation, and how they are starting to provide biological insights into neuropsychiatric disorders. Additionally, we review how assembloids can be used to study properties emerging from cell-cell interactions within non-neural tissues. Overall, assembloid platforms represent a powerful tool for discovering human biology and developing therapeutics.
神经发育涉及各种细胞类型在神经系统不同区域的迁移、投射和整合。组装体是由多个有机体或细胞类型整合而成的自组织系统。在这里,我们概述了组装体的生成和应用。我们阐述了组装体如何再现神经发育的关键步骤,如迁移、轴突投射和回路形成,以及它们如何开始为神经精神疾病提供生物学见解。此外,我们还回顾了组装体如何用于研究非神经组织内细胞-细胞相互作用产生的特性。总之,组装体平台是发现人类生物学和开发疗法的强大工具。
{"title":"Assembloid models of cell-cell interaction to study tissue and disease biology","authors":"Massimo M. Onesto, Ji-il Kim, Sergiu P. Pasca","doi":"10.1016/j.stem.2024.09.017","DOIUrl":"https://doi.org/10.1016/j.stem.2024.09.017","url":null,"abstract":"Neurodevelopment involves the migration, projection, and integration of various cell types across different regions of the nervous system. Assembloids are self-organizing systems formed by the integration of multiple organoids or cell types. Here, we outline the generation and application of assembloids. We illustrate how assembloids recapitulate critical neurodevelopmental steps, like migration, axon projection, and circuit formation, and how they are starting to provide biological insights into neuropsychiatric disorders. Additionally, we review how assembloids can be used to study properties emerging from cell-cell interactions within non-neural tissues. Overall, assembloid platforms represent a powerful tool for discovering human biology and developing therapeutics.","PeriodicalId":9665,"journal":{"name":"Cell stem cell","volume":"30 1","pages":""},"PeriodicalIF":23.9,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142489210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cell stem cell
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1